FTSE 100
10.363,93
PKT
-14,89
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.02.26 | International Consolidated Airlines Outperform | Bernstein Research | |
| 27.02.26 | International Consolidated Airlines Sell | UBS AG | |
| 27.02.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 27.02.26 | International Consolidated Airlines Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 27.02.26 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 27.02.26 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 27.02.26 | Rolls-Royce Buy | Deutsche Bank AG | |
| 27.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 27.02.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 27.02.26 | International Consolidated Airlines Outperform | Bernstein Research | |
| 26.02.26 | Rolls-Royce Outperform | RBC Capital Markets | |
| 26.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 26.02.26 | Diageo Neutral | UBS AG | |
| 26.02.26 | GSK Underweight | Barclays Capital | |
| 26.02.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 26.02.26 | Rolls-Royce Outperform | RBC Capital Markets | |
| 26.02.26 | Diageo Overweight | Barclays Capital | |
| 26.02.26 | Rolls-Royce Market-Perform | Bernstein Research | |
| 26.02.26 | London Stock Exchange (LSE) Overweight | Barclays Capital | |
| 26.02.26 | HSBC Hold | Deutsche Bank AG | |
| 26.02.26 | Diageo Hold | Deutsche Bank AG | |
| 26.02.26 | International Consolidated Airlines Buy | Deutsche Bank AG | |
| 26.02.26 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 26.02.26 | Rolls-Royce Buy | UBS AG | |
| 26.02.26 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 26.02.26 | Diageo Outperform | Bernstein Research | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 26.02.26 | GSK Neutral | UBS AG | |
| 26.02.26 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.02.26 | Diageo Overweight | Barclays Capital | |
| 25.02.26 | GSK Underweight | Barclays Capital | |
| 25.02.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 25.02.26 | Diageo Outperform | RBC Capital Markets | |
| 25.02.26 | Diageo Overweight | Barclays Capital | |
| 25.02.26 | Diageo Neutral | UBS AG | |
| 25.02.26 | HSBC Neutral | UBS AG | |
| 25.02.26 | London Stock Exchange (LSE) Buy | UBS AG | |
| 25.02.26 | Diageo Buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.